Company Filing History:
Years Active: 2000
Title: Brent Cochran: Innovator in Nucleic Acid Research
Introduction
Brent Cochran is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acids. His work has implications for both diagnostic and therapeutic applications.
Latest Patents
Brent Cochran holds a patent for "Nucleic acid encoding vertebrate cdc37." This patent discloses substantially pure nucleic acid sequences that encode vertebrate cdc37. The protein encoded by this nucleic acid is characterized by its ability to bind specifically to various mammalian proteins, including cdk4, cyclin D, cdk2, Rb, hsp90, hsp60, hsp70, Raf-1, MEK-1, SAPK, MAPK, ERK1, P13-K, and the src family of tyrosine kinases. Additionally, the protein is noted for its ability to bind glycosaminoglycan. The patent also outlines diagnostic and therapeutic applications based on the isolation of these nucleic acid sequences. Brent Cochran has 1 patent to his name.
Career Highlights
Brent Cochran is affiliated with Tufts University, where he continues to advance his research in molecular biology. His work has garnered attention for its potential applications in medicine and biotechnology.
Collaborations
Brent has collaborated with notable colleagues, including Nicholas Grammatikakis and Aliki Grammatikakis. Their combined expertise contributes to the innovative research being conducted at Tufts University.
Conclusion
Brent Cochran's contributions to nucleic acid research highlight the importance of innovation in the field of molecular biology. His patent on vertebrate cdc37 showcases the potential for significant advancements in diagnostic and therapeutic applications.